Michel Muálem de Moraes Alves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michel Muálem de Moraes Alves has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Aécio de Amorim Carvalho
Graduate Program in Pharmaceutical Sciences, Federal University of Piauí, Teresina, Brazil
17 shared publications - Daniel Dias Rufino Arcanjo
Universidade Federal do Piauí
16 shared publications Fernando Aécio de Amorim Carvalho
BioLeish (Advanced Research in Leishmania and Alternative Models), Medicinal Plants Research Center, Campus Ministro Petrônio Portella, Federal University of Piauí, TeresinaPiauí, 64049-550, Brazil
6 shared publications- André Luis Menezes Carvalho
Graduate Program in Pharmaceutical Sciences, Federal University of Piauí, Teresina, Brazil
5 shared publications - Alessandra Durazzo
CREA–Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy
4 shared publications - Antônia Maria das Graças Lopes Citó
Federal University of Piauí, Teresina 64049-550, Brazil
4 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (8) , 12599-12612
Limonene and carvacrol combined with drugs that inhibit ergosterol synthesis are potent against Leishmania major
Leishmaniases are neglected diseases widely distributed in tropical and subtropical countries, caused by parasites of the Leishmania genus. Current therapy includes pentavalent antimonial and amphotericin B, but adverse effects persist. The development of a new, more selective, and less toxic combination therapy is therefore a rational and promising approach. In this study, we report the effects of combinations of the monoterpenes limonene (Lim) and carvacrol (Car) with drugs targeting ergosterol biosynthesis, namely nystatin (Nys), tioconazole (Tio), and rosuvastatin (Ros), on Leishmania major , their cytotoxicity on macrophages, and we evaluate their synergism and mechanisms of action. The combinations inhibited the growth of L. major promastigotes, with Lim-Car combined with nystatin (3:2) exhibiting the highest activity, showing an IC 50 of 2.02 µg/mL. Furthermore, this combination demonstrated greater action against amastigotes (IC 50 of 0.53 µg/mL) and a high selectivity index (33.60). Low cytotoxicity was observed in murine macrophages (CC 50 17.81 µg/mL), as well as a low hemolytic potential (CH 50 of > 100 µg/mL). The Lim-Car and nystatin (3:2) combination presented a synergistic effect, with a fractional inhibitory concentration index of 0.4. Changes in parasite membrane integrity were also observed, which may be linked to the interaction of nystatin with the enzyme 14-alpha demethylase, along with an increase in TNF-α expression and a reduction in IL-10 and IL-6 levels. These results suggest that the combination of Lim-Car with Nys (3:2) may exert a summative effect through multiple biochemical pathways and warrants further investigation as a potential combined therapy with antileishmanial activity.
- 16 March 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (8) , 12599-12612
Open AccessLimonene and carvacrol combined with drugs that inhibit ergosterol synthesis are potent against Leishmania major
Leishmaniases are neglected diseases widely distributed in tropical and subtropical countries, caused by parasites of the Leishmania genus. Current therapy includes pentavalent antimonial and amphotericin B, but adverse effects persist. The development of a new, more selective, and less toxic combination therapy is therefore a rational and promising approach. In this study, we report the effects of combinations of the monoterpenes limonene (Lim) and carvacrol (Car) with drugs targeting ergosterol biosynthesis, namely nystatin (Nys), tioconazole (Tio), and rosuvastatin (Ros), on Leishmania major , their cytotoxicity on macrophages, and we evaluate their synergism and mechanisms of action. The combinations inhibited the growth of L. major promastigotes, with Lim-Car combined with nystatin (3:2) exhibiting the highest activity, showing an IC 50 of 2.02 µg/mL. Furthermore, this combination demonstrated greater action against amastigotes (IC 50 of 0.53 µg/mL) and a high selectivity index (33.60). Low cytotoxicity was observed in murine macrophages (CC 50 17.81 µg/mL), as well as a low hemolytic potential (CH 50 of > 100 µg/mL). The Lim-Car and nystatin (3:2) combination presented a synergistic effect, with a fractional inhibitory concentration index of 0.4. Changes in parasite membrane integrity were also observed, which may be linked to the interaction of nystatin with the enzyme 14-alpha demethylase, along with an increase in TNF-α expression and a reduction in IL-10 and IL-6 levels. These results suggest that the combination of Lim-Car with Nys (3:2) may exert a summative effect through multiple biochemical pathways and warrants further investigation as a potential combined therapy with antileishmanial activity.
- 23 January 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (2) , 83
Correction: Amphotericin B-Loaded Bigel: Characterization and in vivo Antileishmanial Evaluation in BALB/c Mice Infected with Leishmania amazonensis
- 23 January 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (2) , 83
Correction: Amphotericin B-Loaded Bigel: Characterization and in vivo Antileishmanial Evaluation in BALB/c Mice Infected with Leishmania amazonensis
- 9 January 2026
- Published by Elsevier in Food Chemistry
- Vol. 503, 147891
Obtaining and characterizing bacuri (Platonia insignis) seed flour: a strategy for valuing fruit co-products from a sustainable food perspective
- 9 January 2026
- Published by Elsevier in Food Chemistry
- Vol. 503, 147891
Obtaining and characterizing bacuri (Platonia insignis) seed flour: a strategy for valuing fruit co-products from a sustainable food perspective
- 8 January 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 65
Amphotericin B-Loaded Bigel: Characterization and in vivo Antileishmanial Evaluation in BALB/c Mice Infected with Leishmania amazonensis
American Tegumentary Leishmaniasis (ATL) is a zoonotic disease characterized by polymorphic cutaneous and mucosal manifestations, caused by protozoa of the
- 8 January 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 65
Amphotericin B-Loaded Bigel: Characterization and in vivo Antileishmanial Evaluation in BALB/c Mice Infected with Leishmania amazonensis
American Tegumentary Leishmaniasis (ATL) is a zoonotic disease characterized by polymorphic cutaneous and mucosal manifestations, caused by protozoa of the
- 27 May 2025
- Published by Elsevier in Experimental Parasitology
- Vol. 274, 108966
Topical formulation of Oseltamivir promotes clinical improvement and reduction of parasite load in BALB/c mice infected with Leishmania major
- 27 May 2025
- Published by Elsevier in Experimental Parasitology
- Vol. 274, 108966
Topical formulation of Oseltamivir promotes clinical improvement and reduction of parasite load in BALB/c mice infected with Leishmania major
- 19 May 2025
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 88 (18) , 727-747
Toxicological safety, antioxidant effect, and chemoprotection determination of an extract from the babassu mesocarp ( Orbignya phalerata Mart.) in preclinical studies
Reactive nitrogen species (RNS) and reactive oxygen species (ROS) play a key role in chronic diseases and aging by initiating protein oxidation, impaired cellular membrane damage and functions, and induction of DNA mutations. When endogenous antioxidants are insufficient to counteract oxidant stress, bioactive compounds might serve as physiological therapeutic agents attributed to their ability to neutralize ROS. The aim of this study was to examine the antioxidant, chemoprotective and toxicological aspects of the hydroethanolic extract from Orbignya phalerata Mart. mesocarp using in vitro and in vivo bioassays. The extract presented 9.9 mg/g of total flavonoids, primarily catechin and epicatechin. This extract exhibited no apparent toxicity upon Artemia salina (LC50 > 1000 μg/ml) or Zophobas morio larvae (LD50 > 3000 mg/kg), low hemolysis, genotoxicity, or mutagenicity utilizing Allium cepa cells. Cytotoxicity effects were observed on in L-929 murine fibroblast only at concentrations above 130 μg/ml. This extract effectively neutralized free radicals [DPPH• (EC50 25.3 μg/ml) and ABTS•+ (EC50 52.6 μg/ml)] and reduced H2O2-initiated effects on Saccharomyces cerevisiae. The chemoprotective activity of this extract was also noted in A. salina, L-929 cells, and S. cerevisiae as evidenced from oxidative damage and toxicity tests results. This constitutes the first report describing the toxicological safety profile of a babassu mesocarp extract a rich source of flavonoids (catechin and epicatechin) with antioxidant and chemoprotective activities.
- 19 May 2025
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 88 (18) , 727-747
Toxicological safety, antioxidant effect, and chemoprotection determination of an extract from the babassu mesocarp ( Orbignya phalerata Mart.) in preclinical studies
Reactive nitrogen species (RNS) and reactive oxygen species (ROS) play a key role in chronic diseases and aging by initiating protein oxidation, impaired cellular membrane damage and functions, and induction of DNA mutations. When endogenous antioxidants are insufficient to counteract oxidant stress, bioactive compounds might serve as physiological therapeutic agents attributed to their ability to neutralize ROS. The aim of this study was to examine the antioxidant, chemoprotective and toxicological aspects of the hydroethanolic extract from Orbignya phalerata Mart. mesocarp using in vitro and in vivo bioassays. The extract presented 9.9 mg/g of total flavonoids, primarily catechin and epicatechin. This extract exhibited no apparent toxicity upon Artemia salina (LC50 > 1000 μg/ml) or Zophobas morio larvae (LD50 > 3000 mg/kg), low hemolysis, genotoxicity, or mutagenicity utilizing Allium cepa cells. Cytotoxicity effects were observed on in L-929 murine fibroblast only at concentrations above 130 μg/ml. This extract effectively neutralized free radicals [DPPH• (EC50 25.3 μg/ml) and ABTS•+ (EC50 52.6 μg/ml)] and reduced H2O2-initiated effects on Saccharomyces cerevisiae. The chemoprotective activity of this extract was also noted in A. salina, L-929 cells, and S. cerevisiae as evidenced from oxidative damage and toxicity tests results. This constitutes the first report describing the toxicological safety profile of a babassu mesocarp extract a rich source of flavonoids (catechin and epicatechin) with antioxidant and chemoprotective activities.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 97 (4) , e20250377
Antileishmanial Activity of Oseltamivir and Acyclovir: Modulation of Macrophage Phagocytosis and Cytotoxicity Assessment
Leishmaniasis is a group of diseases caused by protozoa of the genus Leishmania. Current treatments exhibit high toxicity, high costs, and parasite resistance. Consequently, the search for new drugs is of utmost importance, and drug repositioning may offer an alternative for combating the disease. This study aimed to evaluate the antileishmanial and cytotoxic activities, as well as macrophage activation parameters, of oseltamivir (OSV) and acyclovir (ACV). The substances demonstrated antileishmanial activity. The median inhibitory concentration (IC50) values of OSV against different species (L. amazonensis, L. braziliensis, L. infantum, and L. major) were 252.321, 268.161, 29.207, and 143.859 μg/mL, respectively. For ACV, the IC50 values were 25.726, 45.552, 580.741, and 608.981 μg/mL, respectively. The median cytotoxic concentrations (CC50) of OSV and ACV were 512.17 and 2568.75 μg/mL, respectively. Both OSV and ACV significantly reduced the percentage of infected macrophages, with a selectivity index (SI) >20. Additionally, OSV and ACV increased phagocytic capacity but did not enhance lysosomal activity or significantly induce nitric oxide synthesis. Further investigations are necessary to evaluate these substances in experimental in vivo infection models.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 97 (4) , e20250377
Open AccessAntileishmanial Activity of Oseltamivir and Acyclovir: Modulation of Macrophage Phagocytosis and Cytotoxicity Assessment
Leishmaniasis is a group of diseases caused by protozoa of the genus Leishmania. Current treatments exhibit high toxicity, high costs, and parasite resistance. Consequently, the search for new drugs is of utmost importance, and drug repositioning may offer an alternative for combating the disease. This study aimed to evaluate the antileishmanial and cytotoxic activities, as well as macrophage activation parameters, of oseltamivir (OSV) and acyclovir (ACV). The substances demonstrated antileishmanial activity. The median inhibitory concentration (IC50) values of OSV against different species (L. amazonensis, L. braziliensis, L. infantum, and L. major) were 252.321, 268.161, 29.207, and 143.859 μg/mL, respectively. For ACV, the IC50 values were 25.726, 45.552, 580.741, and 608.981 μg/mL, respectively. The median cytotoxic concentrations (CC50) of OSV and ACV were 512.17 and 2568.75 μg/mL, respectively. Both OSV and ACV significantly reduced the percentage of infected macrophages, with a selectivity index (SI) >20. Additionally, OSV and ACV increased phagocytic capacity but did not enhance lysosomal activity or significantly induce nitric oxide synthesis. Further investigations are necessary to evaluate these substances in experimental in vivo infection models.
- Open Access
- 18 September 2024
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 24 (49) , e15694
Efeitos da suplementação do aminoácido L-Citrulina na infecção experimental por Leishmania infantum (Syn. L. chagasi)
Introdução: A Leishmania infantum é o agente etiológico causador da leishmaniose visceral, doença que afeta milhões de pessoas ao redor do mundo. Este estudo explora o potencial terapêutico da suplementação com L-Citrulina, um aminoácido não essencial, na modulação da resposta imune e atenuação da progressão dessa doença em modelos murinos. Métodos: Os animais foram distribuídos em dois grupos de acordo com o início da suplementação de L-citrulina: tratamento prévio (Grupo A) e tratamento sincrônico (Grupo B), cada um contendo 20 animais. Após 7 dias do início da suplementação no grupo A, 10 camundongos dos grupos A e B foram inoculados com 1x106 promatigotas de L. infantum e os demais receberam solução salina. Após 7 dias de infecção, todos os animais foram analisados clinicamente. Além disso, estes tiveram o peso corporal analisado em três momentos: 7 dias antes da infecção, no dia da infecção e após 7 dias de infecção ao final, os valores foram tabelados e analisados estatisticamente. Resultados: Foi possível verificar que suplementação de L-Citrulina resultou em um maior percentual de ganho de peso corporal nos animais tanto infectados quanto não infectados nos períodos analisados. No grupo tratado sincronicamente com a infecção, os animais infectados apresentaram ganho de peso significativo quando comparado ao que receberam solução salina. Conclusão: A suplementação de L-Citrulina pode enquadrar-se como uma estratégia nutricional promissora durante tratamento da infecção por L. infantum, logo, torna-se interessante avaliar os efeitos do uso desse aminoácido em humanos e em outras doenças hipercatabolicas.
- 18 September 2024
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 24 (49) , e15694
Open AccessEfeitos da suplementação do aminoácido L-Citrulina na infecção experimental por Leishmania infantum (Syn. L. chagasi)
Introdução: A Leishmania infantum é o agente etiológico causador da leishmaniose visceral, doença que afeta milhões de pessoas ao redor do mundo. Este estudo explora o potencial terapêutico da suplementação com L-Citrulina, um aminoácido não essencial, na modulação da resposta imune e atenuação da progressão dessa doença em modelos murinos. Métodos: Os animais foram distribuídos em dois grupos de acordo com o início da suplementação de L-citrulina: tratamento prévio (Grupo A) e tratamento sincrônico (Grupo B), cada um contendo 20 animais. Após 7 dias do início da suplementação no grupo A, 10 camundongos dos grupos A e B foram inoculados com 1x106 promatigotas de L. infantum e os demais receberam solução salina. Após 7 dias de infecção, todos os animais foram analisados clinicamente. Além disso, estes tiveram o peso corporal analisado em três momentos: 7 dias antes da infecção, no dia da infecção e após 7 dias de infecção ao final, os valores foram tabelados e analisados estatisticamente. Resultados: Foi possível verificar que suplementação de L-Citrulina resultou em um maior percentual de ganho de peso corporal nos animais tanto infectados quanto não infectados nos períodos analisados. No grupo tratado sincronicamente com a infecção, os animais infectados apresentaram ganho de peso significativo quando comparado ao que receberam solução salina. Conclusão: A suplementação de L-Citrulina pode enquadrar-se como uma estratégia nutricional promissora durante tratamento da infecção por L. infantum, logo, torna-se interessante avaliar os efeitos do uso desse aminoácido em humanos e em outras doenças hipercatabolicas.
- Open Access
- 20 November 2023
- Published by Universidade Federal de Santa Maria in Ciência e Natura
- Vol. 45, e32
Phytochemical, cytotoxic, antileishmania and antimicrobial potentials of Rhodes grass (Chloris gayana Kunth)
The present study aimed to analyze the cytotoxic and antimicrobial activity of the plant Chloris gayana Kunth (Poaceae) proceeding from the ethanol extract, taking into consideration its major secondary metabolites, such as alkaloids, triterpenes, steroids, flavonoids, and tannins. The ethanol extract showed no antimicrobial activity against Staphylococcus aureus, Escherichia coli and Candida krusei. However, the ethanol extract was able to potentiate the activity of amikacin against a strain of S. aureus MRSA (methicillin resistant S. aureus), suggesting a possible application of the extract itself or its isolated phytochemicals, as adjuvants of amikacin in the treatment of infections caused by MRSA strains resistant to this antibiotic. Potential antileishmanial activity was observed, but further research on the isolated action of these metabolites is needed.
- 20 November 2023
- Published by Universidade Federal de Santa Maria in Ciência e Natura
- Vol. 45, e32
Open AccessPhytochemical, cytotoxic, antileishmania and antimicrobial potentials of Rhodes grass (Chloris gayana Kunth)
The present study aimed to analyze the cytotoxic and antimicrobial activity of the plant Chloris gayana Kunth (Poaceae) proceeding from the ethanol extract, taking into consideration its major secondary metabolites, such as alkaloids, triterpenes, steroids, flavonoids, and tannins. The ethanol extract showed no antimicrobial activity against Staphylococcus aureus, Escherichia coli and Candida krusei. However, the ethanol extract was able to potentiate the activity of amikacin against a strain of S. aureus MRSA (methicillin resistant S. aureus), suggesting a possible application of the extract itself or its isolated phytochemicals, as adjuvants of amikacin in the treatment of infections caused by MRSA strains resistant to this antibiotic. Potential antileishmanial activity was observed, but further research on the isolated action of these metabolites is needed.
- Open Access
- 1 September 2023
- Published by MDPI AG in Journal of Composites Science
- Vol. 7 (9) , 368
Solid Lipid Nanoparticles from Platonia insignis Seeds, a Brazilian Amazon Fruit: Characterization, In Vitro and In Vivo Toxicological and Antioxidant Activities
Solid Lipid Nanoparticles (SLNs) are drug delivery systems with important advantages over conventional nanosystems. Considering previously reported pharmacological and physicochemical properties of Platonia insignis seed butter (BBI), this work aimed at developing, characterizing and performing toxicological and antioxidant studies of SLNs produced from BBI. The GC-MS analysis identified palmitic and oleic acids as the major compounds. Three SLN prototypes were developed through high-shear homogenization followed by ultrasonication. During a 180-day stability evaluation, the formulation SLN/TW-1.5 presented greater stability since pH was around 6.0, as well as a lesser variation of the PdI (Polydispersity Index), particle size and Zeta Potential (ZP), confirmed with Raman Spectroscopy and Atomic Force Microscopy (AFM). The CC50 in macrophages was around 249.4 µg∙mL−1 for BBI, whereas the CC50 value for SLN/TW-1.5 was 45.2 µg∙mL−1. Electron Paramagnetic Resonance (EPR) showed a marked in vitro antioxidant activity for BBI and SLN/TW-1.5. After in vivo SLN/TW-1.5 administration in Zophobas morio larvae, assessment of reduced glutathione (GSH), nitrite (NO2−) and myeloperoxidase (MPO) demonstrated antioxidant activity. Thus, the intrinsic physicochemical properties of BBI allowed the development of an optimized nanoformulation with high stability indexes, besides the great potential for antioxidant applications.
- 1 September 2023
- Published by MDPI AG in Journal of Composites Science
- Vol. 7 (9) , 368
Open AccessSolid Lipid Nanoparticles from Platonia insignis Seeds, a Brazilian Amazon Fruit: Characterization, In Vitro and In Vivo Toxicological and Antioxidant Activities
Solid Lipid Nanoparticles (SLNs) are drug delivery systems with important advantages over conventional nanosystems. Considering previously reported pharmacological and physicochemical properties of Platonia insignis seed butter (BBI), this work aimed at developing, characterizing and performing toxicological and antioxidant studies of SLNs produced from BBI. The GC-MS analysis identified palmitic and oleic acids as the major compounds. Three SLN prototypes were developed through high-shear homogenization followed by ultrasonication. During a 180-day stability evaluation, the formulation SLN/TW-1.5 presented greater stability since pH was around 6.0, as well as a lesser variation of the PdI (Polydispersity Index), particle size and Zeta Potential (ZP), confirmed with Raman Spectroscopy and Atomic Force Microscopy (AFM). The CC50 in macrophages was around 249.4 µg∙mL−1 for BBI, whereas the CC50 value for SLN/TW-1.5 was 45.2 µg∙mL−1. Electron Paramagnetic Resonance (EPR) showed a marked in vitro antioxidant activity for BBI and SLN/TW-1.5. After in vivo SLN/TW-1.5 administration in Zophobas morio larvae, assessment of reduced glutathione (GSH), nitrite (NO2−) and myeloperoxidase (MPO) demonstrated antioxidant activity. Thus, the intrinsic physicochemical properties of BBI allowed the development of an optimized nanoformulation with high stability indexes, besides the great potential for antioxidant applications.